The post Pancreatic Cancer Vaccine Shows Potential in Early Trial appeared first on Reason.com.

But sometimes life throws us curveballs, like a major health issue. It's no fun to navigate treatment for cancer or other ...

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...

Pancreatic cancer has a low survival rate and is usually found too late — this new test may help change that Researchers have ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

The FDA granted RMAT designation to nogapendekin alfa and CAR-NK for reversing lymphopenia in patients with cancer, with ...

A rapid nanosensor assay that measures serum protease cleavage of a target-probe nanosensor can identify pancreatic du ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

Pancreatic cancer is the third leading cause of cancer-related deaths in the country. The Ramone Foundation is hosting a ...